Financials
- Market Capitalization 487.04 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.53
市销率
8.08
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2919 | CCCC C4 Therapeutics, Inc. - Common Stock | 4.10 USD | -3.30% | +3.02% | +18.84% | +62.06% | 504.40 M USD | ||
| 2931 | PRLD Prelude Therapeutics Incorporated - Common Stock | 5.84 USD | -7.89% | -11.38% | +25.86% | +352.71% | 466.05 M USD | ||
| 2948 | PRTA Prothena Corporation plc - Ordinary Shares | 9.31 USD | +2.42% | +0.32% | +7.75% | +12.58% | 477.95 M USD | ||
| 2951 | RLMD Relmada Therapeutics, Inc. - Common Stock | 4.41 USD | -2.43% | -4.75% | -15.68% | +431.33% | 470.41 M USD |